Skip to main
CTSH

CTSH Stock Forecast & Price Target

CTSH Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 14%
Buy 29%
Hold 57%
Sell 0%
Strong Sell 0%

Bulls say

Cognizant Tech Solns is favorably positioned because its core businesses are showing resilience in key verticals, with Financial Services revenue at $1.64 billion in the quarter, Technology within CMT representing roughly 50% of that segment and still growing in double digits, and health sciences demand partly offsetting payer and macro-driven softness elsewhere. Its outlook is further supported by improving commercial momentum, including a recent pickup in large deals with $100m+ TCV, rising outsourcing and AI-related demand, and a management view that productivity expectations have effectively doubled from historical 3-4% annual assumptions to 6-8%, which should help offset pricing pressure and support margin expansion. The company’s financial discipline also reinforces the bullish case, as it expects FY26 revenue of $22.11 billion to $22.64 billion, operating margin of 16.0%-16.2%, and continued shareholder returns through essentially 100% of annual free cash flow, while balance sheet flexibility and acquisition activity can add platform, IP, cybersecurity, modernization, and geographic scale.

Bears say

Cognizant Tech Solns is facing a negative outlook because its core growth engine is increasingly exposed to AI-driven productivity pressure, tougher customer procurement, and a macro backdrop that is already forcing more cautious discretionary spending assumptions, while management itself noted that lower IT spending and uncertain macro conditions could weigh on near-term growth. Although the company posted $5.41 billion of revenue and a 11% increase in TTM bookings to $29.6 billion with a ~1.4x book-to-bill, much of that demand is tied to longer-duration large deals that take time to convert, and segments such as Health Sciences weakened while free cash flow fell sharply to $198.0 million due to a large bonus payout. Project Leap may improve competitiveness over time, but it also brings $230 million to $320 million of 2026 costs, requires substantial reinvestment of expected savings into AI and workforce changes, and underscores that margin expansion to 16.0%–16.2% depends on execution in an environment where revenue mix is still shifting toward fixed-price and transaction-based contracts and where benefits from the transformation may take longer to materialize.

CTSH has been analyzed by 14 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 29% recommend Buy, 57% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cognizant Technology Solutions and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cognizant Technology Solutions (CTSH) Forecast

Analysts have given CTSH a Buy based on their latest research and market trends.

According to 14 analysts, CTSH has a Buy consensus rating as of Oct 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $62.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $62.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cognizant Technology Solutions (CTSH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.